Close Menu

Stanford and Duke University researchers propose a CRISPR-Cas13-based strategy called "prophylactic antiviral CRISPR in human cells" (PAC-MAN) for combating influenza A viruses and coronaviruses such as SARS-CoV-2. The approach relies on RNA-guided inhibition and breakdown of the RNA making up the genomes of these viruses, the team says, and uses CRISPR RNAs aimed at conserved genome regions.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The Lancet and the New England Journal of Medicine have retracted two COVID-19 papers due to concerns about the data used in their analyses.

A new study finds that three dimensional facial scans may be able to aid in diagnosing rare genetic diseases.

Lawmakers plan to introduce a bill that aims to prevent the theft of US-funded research, according to the Wall Street Journal.

In Science this week: analysis of ancient Caribbean islanders' genomes suggests at least three waves of migration into the region,  DNA barcoding of microbial spores, and more.